Cargando…
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
Avatrombopag is an orally-administered small molecule thrombopoietin receptor agonist. It was the third thrombopoietin receptor agonist approved for the treatment of immune thrombocytopenia and the first approved to treat periprocedural thrombocytopenia in patients with chronic liver disease (thereb...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733339/ https://www.ncbi.nlm.nih.gov/pubmed/31565009 http://dx.doi.org/10.2147/JBM.S191790 |